Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide (Q57252641)

0 references

GR Hill

0 references

P Hunt

0 references

S Carnoutsos

0 references

E Espiner

0 references

DNJ Hart

Bone Marrow Transplantation

0 references

language of work or name

English

0 references

publication date

28 July 2000

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

309-313

0 references

cites work

Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Cardiovascular dysfunction in septic shock: new insights into a deadly disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

A new natriuretic peptide in porcine brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Atrial natriuretic factor—a circulating hormone stimulated by volume loading

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Plasma brain natriuretic peptide in assessment of acute dyspnoea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Adverse effects of febrile state on cardiac performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Cardiac involvement in bone marrow transplantation: serial changes in left ventricular size, mass and performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Cardiac pathologic findings in patients treated with bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021

Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702507

7 January 2021